David Agus is a professor of medicine and engineering at the University of Southern California Keck School of Medicine and Viterbi School of Engineering and heads USC’s Westside Cancer Center and the Center for Applied Molecular Medicine. He is one of the world’s leading cancer doctors and the co-founder of two pioneering personalized medicine companies, Navigenics and Applied Proteomics. Agus is an international leader in new technologies and approaches for personalized health care and chairs the Global Agenda Council on Genetics for the World Economic Forum. He has received numerous awards, including the 2009 Geoffrey Beene Foundation’s Rockstar of Science Award. Agus’s first book, The End of Illness, was published in January and is a New York Times best-seller. @DavidAgus